CNXU — Conexeu Sciences Inc.

CNXUConexeu Sciences Inc.

NAS · US · Healthcare · Biotechnology · conexeu.com

14.00USD+22.00%Mkt Cap: —P/E: —Last update: 2026-06-01

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a co…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value235.96M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-3.92M USD

Revenue/Share—

Last Price14.00 USD

Fiscal Year EndOct 2025

MR QuarterJan 2026

Employees—

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-44.48

EV/Revenue—

P/S—

P/B34.08

EPS (TTM)-0.26

EPS (Forward)—

52W Range

10.8747% of range17.50

52W High17.50 USD

52W Low10.87 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-53.36%

ROA-51.03%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.67M USD

CapEx (TTM)18.67K USD

FCF Margin—

FCF Yield—

Net Debt-6.25M USD

Net Debt/EBITDA1.18

Balance Sheet

Debt/Equity0.06

Current Ratio8.51

Quick Ratio7.14

Book Value/Sh0.3440 USD

Cash/Share0.2990 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float—

Insiders—

Institutions—

Technical

SMA 5013.29 (+5.3%)

SMA 20013.29 (+5.3%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)66.77K

Avg Vol (10d)50.84K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—